Literature DB >> 10203182

Harmful effects of UVA on the structure and barrier function of engineered human cutaneous tissues.

M Robert1, V Bissonauth, G Ross, M Rouabhia.   

Abstract

PURPOSE: To investigate the effects of a single UVA exposure on engineered human cutaneous tissues.
MATERIALS AND METHODS: Skin equivalents (SE) were obtained by culturing keratinocytes on fibroblast-populated collagen gels; epidermal equivalents (EE) were obtained by seeding keratinocytes on non-populated collagen gels. After maturation and differentiation of the epidermis, SE and EE were exposed to 50 or 100 J/cm2 UVA. Structural damage and total epidermal lipids were analysed and diffusion of radioactive oestradiol was monitored 24 and 72h post-irradiation.
RESULTS: Twenty-four hours after UVA irradiation, a disorganization of the living epidermis is observed. UVA also significantly reduced the skin barrier function and led to an increase in phospholipid and in a decrease of ceramide levels. However, both the structure and the barrier function of SE were recovered 72 h post-irradiation, thereby suggesting that an intrinsic repair process might exist within the irradiated SE.
CONCLUSION: This study provides a strong evidence that UVA radiation alters both the epidermal and dermal structures, the synthesis of epidermal lipids, and the permeability of the human skin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203182     DOI: 10.1080/095530099140492

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  2 in total

Review 1.  Xenobiotic bioconversion in human epidermis models.

Authors:  Audra L Stinchcomb
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

2.  The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure.

Authors:  Jodi L Johnson; Jennifer L Koetsier; Anna Sirico; Ada T Agidi; Dario Antonini; Caterina Missero; Kathleen J Green
Journal:  J Invest Dermatol       Date:  2014-03-04       Impact factor: 8.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.